Conduit Pharmaceuticals News

3: Initial statement of beneficial ownership of securities-10% Owner Nirland Ltd

Aug 14 04:35

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nirland Limited(14.8%),Stockton Limited(14.8%), etc.

Aug 14 04:33

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

Jun 12 05:58

4: Statement of changes in beneficial ownership of securities-Officer Bligh James

Jun 12 05:58

4: Statement of changes in beneficial ownership of securities-Officer Sragovicz Adam

May 16 10:26

4: Statement of changes in beneficial ownership of securities-Director McNealey Jennifer Isacoff

May 16 04:55

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

Apr 25 05:06

4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

Apr 25 05:06

4: Statement of changes in beneficial ownership of securities-Officer Tapolczay David

Apr 25 05:05

Conduit Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Polar Asset Management Partners Inc.(1.3%)

Feb 13 01:56

Conduit Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Saba Capital Management, L.P.(0%),Boaz R. Weinstein(0%), etc.

Feb 9 02:21

Conduit Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hudson Bay Capital Management LP(0.10%),Sander Gerber(0.10%)

Feb 3 05:33

Conduit Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

Dec 15, 2023 06:16

Conduit Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bligh James

Dec 6, 2023 06:20

Conduit Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

Dec 6, 2023 06:20

Conduit Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director McNealey Jennifer Isacoff

Dec 6, 2023 06:20

Conduit Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.

Dec 6, 2023 06:20

Conduit Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Tapolczay David

Dec 6, 2023 06:20

Conduit Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Sragovicz Adam

Dec 6, 2023 06:20

Conduit Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Nirland Limited(8.8%),Stockton Limited(8.8%), etc.

Oct 3, 2023 04:30